Aldolase is an essential enzyme in glycolysis and fructose metabolism. It is found in two classes.
Class I includes specific isozymes like aldolase A in muscles, B in liver and kidneys, and C in the brain, each associated with unique regulatory functions and genetic coding. Aldolase plays a critical role in several metabolic pathways, and its dysfunction can lead to conditions such as hereditary fructose intolerance.
By facilitating the production of key metabolites, aldolase ensures a steady ATP supply, supporting essential functions like muscle contraction and cellular biosynthesis. Besides its central role in metabolism, aldolase is involved in gluconeogenesis, the pentose phosphate pathway, and cellular processes like signaling and gene regulation.
The measurement of aldolase levels in the blood can provide insights into muscle and liver health, though it is less specific than other markers. Elevated aldolase levels might indicate muscle damage, liver dysfunction, or other serious conditions such as muscular dystrophy, myositis, or liver cirrhosis.
Conversely, reduced aldolase levels might suggest genetic disorders like aldolase A deficiency, leading to hemolytic anemia and exercise intolerance, or fructose intolerance due to inadequate aldolase B activity.
Fructose 1,6-bisphosphate aldolase, commonly known as aldolase, is an enzyme crucial in glycolysis and fructose metabolism, facilitating the conversion of fructose 1,6-bisphosphate into glyceraldehyde 3-phosphate and dihydroxyacetone phosphate.
This enzyme exists in two classes: Class I aldolases, found in animals, plants, and green algae, are known for their structural conservation and tetrameric configuration, while Class II aldolases, found in bacteria, yeasts, and fungi, utilize a metal cation for catalysis and lack primary sequence similarity to Class I.
Each class employs a distinct catalytic mechanism, though they share a common protein fold.
Class I includes isozymes such as aldolase A (muscular), B (liver and kidney), and C (brain), each with unique properties and genetic coding.
Aldolase's function is pivotal in various metabolic pathways, and mutations in these enzymes can lead to metabolic disorders such as hereditary fructose intolerance.
Historically, aldolase was used to assess liver and heart function, although newer tests have replaced this. [1.]
In glycolysis, aldolase bridges the gap between the initial steps of glucose metabolism and the subsequent generation of ATP.
Following its catalytic action, aldolase produces glyceraldehyde-3-phosphate, a precursor for pyruvate formation, and dihydroxyacetone phosphate, which undergoes further conversion to glyceraldehyde-3-phosphate.
These metabolites proceed through subsequent enzymatic reactions, ultimately yielding ATP through substrate-level phosphorylation.
Thus, aldolase's participation in glycolysis ensures a continuous supply of ATP to meet cellular energy demands, supporting vital cellular functions such as muscle contraction, neuronal activity, and biosynthesis.
Aldolase's role in glycolysis extends beyond energy production, influencing various metabolic pathways and physiological processes.
Beyond its canonical function in glucose metabolism, aldolase participates in gluconeogenesis, the synthesis of glucose from non-carbohydrate precursors, and the pentose phosphate pathway, which generates reducing equivalents and pentose sugars for nucleotide biosynthesis.
Moreover, aldolase is implicated in cellular signaling pathways, cytoskeletal organization, and gene expression regulation, highlighting its diverse functions beyond glycolytic metabolism.
The aldolase blood test, commonly known as aldolase assay, entails the quantitative measurement of aldolase levels in blood serum or plasma samples obtained from patients. The procedure typically involves collecting a blood specimen through venipuncture, and may require freezing the sample.
Fasting for at least 8 hours and avoiding strenuous activities beforehand is essential for accurate aldolase blood test results. Failure to do so, as well as certain medications like statins or steroids, can cause muscle breakdown that may lead to artificially high aldolase levels.
In some cases, temporarily discontinuing these medications may be necessary for precise testing.
The test quantifies total enzyme activity and does not distinguish between the specific isoenzymes Aldolase A, B, or C.
The optimal levels of aldolase are reported as: [1.]
Adult: 3-8.2 Sibley-Lehninger units/dL or 22-59 mU/L at 37°C (SI units)
Child: Approximately two times the adult values
Newborn: Approximately four times the adult values
Elevated aldolase levels may indicate muscle damage or liver dysfunction. This is because aldolase is predominantly found in skeletal muscle and hepatocytes (liver cells).
Conditions associated with elevated aldolase levels include
Elevated aldolase levels are a biomarker of muscle or liver damage. Aldolase testing is used to assess muscle and liver health, although it is not as specific as other more targeted tests.
The following conditions are associated with decreased aldolase levels:
In metabolic assessment, aldolase testing often complements other biomarkers that collectively provide valuable insights into metabolic function and dysfunction.
Creatine kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme predominantly found in skeletal muscle and cardiac muscle tissues.
Like aldolase, CK serves as a biomarker for muscle damage and is commonly measured in the diagnostic evaluation of neuromuscular disorders, myocardial infarction, and other conditions affecting muscle integrity.
Elevated CK levels, particularly CK-MB isoform, indicate myocardial injury, while CK-MM isoform elevation suggests skeletal muscle damage.
Combined assessment of aldolase and CK levels enhances the diagnostic specificity and sensitivity for muscle-related pathologies, allowing for accurate differentiation between cardiac and skeletal muscle involvement.
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are enzymes primarily found in hepatocytes, with lesser amounts present in skeletal muscle and other tissues.
Elevations in AST and ALT levels are indicative of liver injury or hepatocellular damage, commonly observed in conditions such as viral hepatitis, alcoholic liver disease, and drug-induced hepatotoxicity.
Concurrent measurement of aldolase, AST, and ALT levels enables comprehensive evaluation of liver function and differentiation between muscle and liver injury etiologies. The AST/ALT ratio may also provide valuable diagnostic information, with elevated ratios suggestive of liver disease.
Lactate dehydrogenase (LDH) is a ubiquitous enzyme involved in anaerobic metabolism and cellular energy production. LDH is present in various tissues, including skeletal muscle, liver, heart, kidneys, and red blood cells.
Elevated LDH levels are nonspecific and may indicate tissue damage or cellular turnover in various organs.
In the context of metabolic assessment, LDH serves as a supplementary biomarker alongside aldolase, providing additional information on tissue injury and metabolic stress.
Serial monitoring of LDH levels aids in disease monitoring and treatment response assessment in conditions such as cancer, tissue ischemia, and inflammatory disorders.
Gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) are enzymes primarily associated with biliary function and hepatobiliary injury.
Elevated GGT and ALP levels are indicative of cholestasis or biliary obstruction, commonly observed in conditions such as cholelithiasis, cholangitis, and biliary tract malignancies.
Combined assessment of aldolase, AST, ALT, GGT, and ALP levels facilitates comprehensive evaluation of liver function and differentiation between hepatocellular and cholestatic liver injury patterns. Additionally, the evaluation of liver function tests aids in the diagnosis and management of liver disorders and guides therapeutic interventions.
Click here to compare testing options and order testing for aldolase.
[1.] Aldolase: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online October 14, 2022. https://emedicine.medscape.com/article/2087158-overview?form=fpf
[2.] Farhana A, Lappin SL. Biochemistry, Lactate Dehydrogenase. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557536/
[3.] Li M, Zhang CS, Feng JW, et al. Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1. Cell Research. 2021;31(4):478-481. doi:https://doi.org/10.1038/s41422-020-00456-8
[4.] McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 2016 Dec 15;15:817-828. doi: 10.17179/excli2016-800. PMID: 28337112; PMCID: PMC5318690.
[5.] McGill MR, Jaeschke H. Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation. Expert Rev Mol Diagn. 2018 Sep;18(9):797-807. doi: 10.1080/14737159.2018.1508998. Epub 2018 Aug 13. PMID: 30080986; PMCID: PMC6288799.
[6.] Pannathat Soontrapa, Shahar S, Lattawat Eauchai, Ernste FC, Teerin Liewluck. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase. European Journal of Neurology. 2023;31(2). doi:https://doi.org/10.1111/ene.16117
[7.] Research. www.bu.edu. Accessed May 7, 2024. https://www.bu.edu/aldolase/lab/research.html#Expression
[8.] Royds JA, Kennedy HJ, Little PV, Taylor CB, Triger DR. Serum aldolase isoenzymes in benign and malignant liver disease. Clin Chim Acta. 1987 Aug 31;167(3):237-46. doi: 10.1016/0009-8981(87)90343-3. PMID: 3621611.
[9.] Taguchi K, Takagi Y. [Aldolase]. Rinsho Byori. 2001 Nov;Suppl 116:117-24. Japanese. PMID: 11797371.
[10.] Tanner LB, Goglia AG, Wei MH, Sehgal T, Parsons LR, Park JO, White E, Toettcher JE, Rabinowitz JD. Four Key Steps Control Glycolytic Flux in Mammalian Cells. Cell Syst. 2018 Jul 25;7(1):49-62.e8. doi: 10.1016/j.cels.2018.06.003. Epub 2018 Jun 27. PMID: 29960885; PMCID: PMC6062487.
[11.] Wu Y, Lu C, Pan N, Zhang M, An Y, Xu M, Zhang L, Guo Y, Tan L. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci Rep. 2021 Jun 21;11(1):12997. doi: 10.1038/s41598-021-92430-6. PMID: 34155288; PMCID: PMC8217520.
[12.] Yao DC, Tolan DR, Murray MF, et al. Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr). Blood. 2004;103(6):2401-2403. doi:https://doi.org/10.1182/blood-2003-09-3160
[13.] Ziveri J, Tros F, Guerrera IC, Chhuon C, Audry M, Dupuis M, Barel M, Korniotis S, Fillatreau S, Gales L, Cahoreau E, Charbit A. The metabolic enzyme fructose-1,6-bisphosphate aldolase acts as a transcriptional regulator in pathogenic Francisella. Nat Commun. 2017 Oct 11;8(1):853. doi: 10.1038/s41467-017-00889-7. PMID: 29021545; PMCID: PMC5636795.